DrugPatentWatch Database Preview

Nexus Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for NEXUS PHARMS, and what generic and branded alternatives to NEXUS PHARMS drugs are available?

NEXUS PHARMS has five approved drugs.

Summary for Nexus Pharms

US Patents:	0
Tradenames:	5
Ingredients:	5
NDAs:	5

Drugs and US Patents for Nexus Pharms

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Nexus Pharms	PROCAINAMIDE HYDROCHLORIDE	procainamide hydrochloride	INJECTABLE;INJECTION	206332-002	Oct 13, 2017	AP	RX	No	No
Nexus Pharms	COLISTIMETHATE SODIUM	colistimethate sodium	INJECTABLE;INJECTION	065177-001	Mar 19, 2004	AP	RX	No	No
Nexus Pharms	PROCAINAMIDE HYDROCHLORIDE	procainamide hydrochloride	INJECTABLE;INJECTION	206332-001	Oct 13, 2017	AP	RX	No	No
Nexus Pharms	TESTOSTERONE ENANTHATE	testosterone enanthate	INJECTABLE;INJECTION	040575-001	Jun 14, 2006	AO	RX	No	No
Nexus Pharms	ISOPROTERENOL HYDROCHLORIDE	isoproterenol hydrochloride	INJECTABLE;INJECTION	206961-001	Aug 2, 2017	AP	RX	No	No
Nexus Pharms	SODIUM NITROPRUSSIDE	sodium nitroprusside	INJECTABLE;INJECTION	207499-001	May 25, 2017	AP	RX	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Nexus Pharms